The global
MRI-guided neurosurgical ablation market report by Metastat Insight encapsulates the current scenario and future prospects of this niche area in detail. Insights into how MRI-guided techniques are changing the neurosurgical procedure landscape with real-time imaging for increased treatment of neurological conditions are outlined in this report.
Top Companies
Abbott Laboratories, AngioDynamics Inc., Boston Scientific Corporation, ClearPoint Neuro Inc., Elekta AB, InSightec Ltd., Medtronic, Monteris Medical Inc., Profound Medical, Varian Medical Systems, Washington University in St. Louis.
All this is due to the fact that MRI-guided neurosurgical ablation is being most preferred as a mode of treatment that allows targeting of brain lesions with an increased degree of accuracy and irrelevance to damage surrounding healthy brain tissues. This is then a great technology for neurosurgeons since it gives them unsurpassed detail on structure visualization and the ability to navigate the brain; hence, undergoing effective and safer treatments. This will directly impact a patient by shortening the procedural time and making the recoveries quicker.
Several factors mould the market for MRI-guided neurosurgical ablation. Improvements in MRI technology, with higher resolution imaging and faster scanning capability, have driven the improvement and adaptation of these procedures. Improvements in MRI-guided systems enable interventions of increasing complexity in neurosurgery with greater confidence and therefore huge potential applications.
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian